✦ LIBER ✦

The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists

✍ Scribed by Eckerle Mize, Dara L.; Salehi, Marzieh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DPP-4 inhibitors and GLP-1 analogues: fo

✍ S. Halimi 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 451 KB

Specific actions of GLP-1 receptor agoni

✍ Stéphane Dalle; Rémy Burcelin; Pierre Gourdy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Pharmacokinetics, safety, and efficacy o

✍ Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 336 KB

Erratum to: Pharmacokinetics, safety, an

✍ Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 154 KB

Effects of multiple doses of the DPP-IV

✍ Stephanie M. Gustavson; Haiqing Dai; Gregory M. Preston; Veena Somayaji; Boaz Hi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 198 KB

[Advances in Experimental Medicine and B

✍ Back, Nathan; Cohen, Irun R.; Kritchevsky, David; Lajtha, Abel; Paoletti, Rodolf 📂 Article 📅 2004 🏛 Kluwer Academic Publishers ⚖ 153 KB